Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Rayos — DELTASONE
Application NDA009986 (NDA)
Rayos — METICORTEN
Application NDA009766 (NDA)
Rayos — PARACORT
Application NDA010962 (NDA)
Rayos — PREDNISONE
Application NDA017109 (NDA)
Rayos — RAYOS
Application NDA202020 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)